PEP
47
-7
MNST
65
2
CRM
59
5
FOXA
66
3
HRL
53
-3
ES
49
2
BWA
57
-4
HUM
48
-4
MHK
70
-3
AIG
56
3
IPG
54
2
FTI
79
15
PX
80
2
SJM
36
-2
IBM
71
3
WHR
68
-4
ADM
51
-2
AAP
42
4
MA
64
4
MKC
63
-2
PEP
47
-7
MNST
65
2
CRM
59
5
FOXA
66
3
HRL
53
-3
ES
49
2
BWA
57
-4
HUM
48
-4
MHK
70
-3
AIG
56
3
IPG
54
2
FTI
79
15
PX
80
2
SJM
36
-2
IBM
71
3
WHR
68
-4
ADM
51
-2
AAP
42
4
MA
64
4
MKC
63
-2
Financhill
Back

Brighthouse Financial Vs. Blueprint Medicines Industry Stock Comparison

Buy
62

BHF
Brighthouse Financial

Last Price:
$53.19
Seasonality Move:
4.31%
Sell
50

BPMC
Blueprint Medicines

Last Price:
$128.39
Seasonality Move:
7.99%
Buy
62
Brighthouse Financial (BHF) is a Buy

Is Brighthouse Financial a Buy, Sell or Hold?

  • The current Brighthouse Financial [BHF] share price is $53.34. The Score for BHF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • BHF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BHF Stock Price Chart

What is Brighthouse Financial's stock price today?

  • The Brighthouse Financial share price today is $53.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BHF is experiencing slight selling pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

BHF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.25 Sell
Relative Strength Index (14 RSI): 36.85 Sell
Chaikin Money Flow: -334046 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.64 - 59.3) Sell
Bollinger Bands (100): (53.27 - 60.33) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.65 Buy
Relative Strength Index (14 RSI): 74.59 Buy
Chaikin Money Flow: 675123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119 - 133.06) Buy
Bollinger Bands (100): (84.56 - 117) Buy

BHF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.71 Sell
20-day SMA: 56.45 Sell
50-day SMA: 57.56 Sell
200-day SMA: 52.87 Buy
8-day EMA: 54.33 Sell
20-day EMA: 55.83 Sell
50-day EMA: 56.57 Sell
200-day EMA: 53.76 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.23 Buy
20-day SMA: 128.14 Buy
50-day SMA: 111.57 Buy
200-day SMA: 97.6 Buy
8-day EMA: 128.16 Buy
20-day EMA: 125.23 Buy
50-day EMA: 115.07 Buy
200-day EMA: 100.77 Buy

Brighthouse Financial Earnings Growth & BHF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.97 per share, a decrease this year of $0.17 per share, and an increase next year of $2.02 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Brighthouse Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):